The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort
Open accessAbstract
BACKGROUND: In addition to HPV, high parity and hormonal contraceptives have been associated with cervical cancer (CC). However, most of the evidence comes from retrospective case-control studies. The aim of this study is to prospectively evaluate associations between hormonal factors and risk of developing cervical intraepithelial neoplasia grade 3 (CIN3)/carcinoma in situ (CIS) and invasive cervical cancer (ICC). METHODS AND FINDINGS: We followed a cohort of 308,036 women recruited in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. At enrollment, participants completed a questionnaire and provided serum. After a 9-year median follow-up, 261 ICC and 804 CIN3/CIS cases were reported. In a nested case-control study, the sera from 609 cases and 1,218 matched controls were tested for L1 antibodies against HPV types 11,16,18,31,33,35,45,52,58, and antibodies against Chlamydia trachomatis and Human herpesvirus 2. Multivariate analyses were performed to estimate hazard ratios (HR), odds ratios (OR) and corresponding 95% confidence intervals (CI). The cohort analysis showed that number of full-term pregnancies was positively associated with CIN3/CIS risk (p-trend = 0.03). Duration of oral contraceptives use was associated with a significantly increased risk of both CIN3/CIS and ICC (HR = 1.6 and HR = 1.8 respectively for ≥ 15 years versus never use). Ever use of menopausal hormone therapy was associated with a reduced risk of ICC (HR = 0.5, 95%CI: 0.4-0.8). A non-significant reduced risk of ICC with ever use of intrauterine devices (IUD) was found in the nested case-control analysis (OR = 0.6). Analyses restricted to all cases and HPV seropositive controls yielded similar results, revealing a significant inverse association with IUD for combined CIN3/CIS and ICC (OR = 0.7). CONCLUSIONS: Even though HPV is the necessary cause of CC, our results suggest that several hormonal factors are risk factors for cervical carcinogenesis. Adherence to current cervical cancer screening guidelines should minimize the increased risk of CC associated with these hormonal risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
Ho, G. Y. F., Bierman, R., Beardsley, L., Chang, C. J., & Burk, R. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380703 · Cited by 2,329
Riboli, E., Hunt, K., Slimani, N., Ferrari, P., Norat, T., Fahey, M., Charrondière, U., Hémon, B., Casagrande, C., Vignat, J., et al. (2002) · Public Health Nutrition · doi:10.1079/phn2002394 · Cited by 1,866
Self-citationChapter 1: HPV in the etiology of human cancer
Muñoz, N., Castellsagué, X., de González, A. B., & Gissmann, L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.115 · Cited by 1,355 · cited 2×
“High parity and hormonal contraceptives have long been recognized as potential cofactors of CC [5].”
Self-citation
Research works printed but not linked: 37
- JG Baseman, 2005, The epidemiology of human papillomavirus infections, J Clin Virol, 32, S16, 10.1016/j.jcv.2004.12.008 · DOI · Paper page
- V Cogliano, 2005, WHO International Agency for Research on Cancer. Carcinogenicity of human papillomaviruses, Lancet Oncol, 6, 204, 10.1016/S1470-2045(05)70086-3 · DOI · Paper page
- 2007, Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy, IARC Monogr Eval Carcinog Risks Hum, 91, 1
- P Appleby, 2007, Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies, Lancet, 370, 1609, 10.1016/S0140-6736(07)61684-5 · DOI · Paper page
- 2006, Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies, Int J Cancer, 119, 1108, 10.1002/ijc.21953 · DOI · Paper page
- S Rinaldi, 2011, Endogenous sex steroids and risk of cervical carcinoma: results from the EPIC study, Cancer Epidemiol Biomarkers Prev, 20, 2532, 10.1158/1055-9965.EPI-11-0753 · DOI
- E Roura, 2014, Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort, Int J Cancer, 135, 453, 10.1002/ijc.28666 · DOI · Paper page
- X Castellsague, 2014, Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort, Int J Cancer, 135, 440, 10.1002/ijc.28665 · DOI
- T Waterboer, 2005, Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins, Clin Chem, 51, 1845, 10.1373/clinchem.2005.052381 · DOI · Paper page
- P Sehr, 2002, HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase, J Virol Methods, 106, 61, 10.1016/S0166-0934(02)00134-9 · DOI
- GM Clifford, 2007, Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea, Cancer Epidemiol Biomarkers Prev, 16, 1874, 10.1158/1055-9965.EPI-07-0349 · DOI
- T Peters, 2012, Validity of a short questionnaire to assess physical activity in 10 European countries, Eur J Epidemiol, 27, 15, 10.1007/s10654-011-9625-y · DOI · Paper page
- V Moreno, 2002, Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study, Lancet, 359, 1085, 10.1016/S0140-6736(02)08150-3 · DOI · Paper page
- PE Castle, 2002, A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women, J Natl Cancer Inst, 94, 1406, 10.1093/jnci/94.18.1406 · DOI · Paper page
- PE Castle, 2005, Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology, Int J Cancer, 117, 1007, 10.1002/ijc.21279 · DOI
- KE Jensen, 2013, Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up, Br J Cancer, 108, 234, 10.1038/bjc.2012.513 · DOI
- JR Daling, 1996, The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection, Cancer Epidemiol Biomarkers Prev, 5, 541
- A Berrington, 2002, Oral contraceptives and cervical cancer, Lancet, 360, 410, 10.1016/S0140-6736(02)09578-8 · doi:10.1016/s0140-6736(02)09578-8
- TS Shields, 2004, A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus, Cancer Epidemiol Biomarkers Prev, 13, 1574, 10.1158/1055-9965.1574.13.10 · DOI
- K Syrjanen, 2006, Oral contraceptives are not an independent risk factor for cervical intraepithelial neoplasia or high-risk human papillomavirus infections, Anticancer Res, 26, 4729
- M Moodley, 2003, The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: a review, Int J Gynecol Cancer, 13, 103, 10.1046/j.1525-1438.2003.13030.x · DOI
- A Gadducci, 2011, Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature, Gynecol Endocrinol, 27, 597, 10.3109/09513590.2011.558953 · DOI · Paper page
- SH Chung, 2010, Estrogen and ERalpha: culprits in cervical cancer?, Trends Endocrinol Metab, 21, 504, 10.1016/j.tem.2010.03.005 · DOI · Paper page
- YA Yoo, 2013, Progesterone signaling inhibits cervical carcinogenesis in mice, Am J Pathol, 183, 1679, 10.1016/j.ajpath.2013.07.026 · DOI
- N Munoz, 2002, Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study, Lancet, 359, 1093, 10.1016/S0140-6736(02)08151-5 · DOI · Paper page
- JV Lacey Jr., 2000, Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix, Gynecol Oncol, 77, 149, 10.1006/gyno.2000.5731 · DOI
- HO Adami, 1989, Risk of cancer in women receiving hormone replacement therapy, Int J Cancer, 44, 833, 10.1002/ijc.2910440515 · DOI · Paper page
- F Parazzini, 1997, Case-control study of oestrogen replacement therapy and risk of cervical cancer, BMJ, 315, 85, 10.1136/bmj.315.7100.85 · DOI
- C Schneider, 2009, Risk of gynecological cancers in users of estradiol/dydrogesterone or other HRT preparations, Climacteric, 12, 514, 10.3109/13697130903075352 · DOI
- F Parazzini, 1989, Reproductive factors and the risk of invasive and intraepithelial cervical neoplasia, Br J Cancer, 59, 805, 10.1038/bjc.1989.168 · doi:10.1038/bjc.1989.168
- C La Vecchia, 1993, Long-term impact of reproductive factors on cancer risk, Int J Cancer, 53, 215, 10.1002/ijc.2910530207 · DOI
- JM Deacon, 2000, Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort, Br J Cancer, 83, 1565, 10.1054/bjoc.2000.1523 · DOI · Paper page
- KT Zondervan, 1996, Oral contraceptives and cervical cancer—further findings from the Oxford Family Planning Association contraceptive study, Br J Cancer, 73, 1291, 10.1038/bjc.1996.247 · doi:10.1038/bjc.1996.247
- E Russo, 2011, Vaginal delivery and low immunity are strongly associated with high-grade cervical intraepithelial neoplasia in a high-risk population, J Low Genit Tract Dis, 15, 195, 10.1097/LGT.0b013e31820918ea · doi:10.1097/lgt.0b013e31820918ea
- X Castellsague, 2011, Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies, Lancet Oncol, 12, 1023, 10.1016/S1470-2045(11)70223-6 · DOI
- 2007, Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies, Int J Cancer, 120, 885, 10.1002/ijc.22357 · DOI · Paper page
- X Castellsague, 2006, Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention, J Natl Cancer Inst, 98, 303, 10.1093/jnci/djj067 · DOI · Paper page
Cited by
The natural history of human papillomavirus infection
de Sanjosé, S., Brotons, M., & Pavón, M. A. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2017.08.015 · Cited by 589
Self-citationGuidelines of care for the management of acne vulgaris
Reynolds, R. V., Yeung, H., Cheng, C. E., Cook-Bolden, F., Desai, S. R., Druby, K. M., Freeman, E. E., Keri, J. E., Stein Gold, L. F., Tan, J. K. L., et al. (2024) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2023.12.017 · Cited by 518
Hamoda, H., Panay, N., Pedder, H., Arya, R., & Savvas, M. (2020) · Post Reproductive Health · doi:10.1177/2053369120957514 · Cited by 192
Metadata
- Authors
- Roura, E., Travier, N., Waterboer, T., de Sanjosé, S., Bosch, F. X., Pawlita, M., Pala, V., Weiderpass, E., Margall, N., Dillner, J., Gram, I. T., Tjønneland, A., Munk, C., Palli, D., Khaw, K.-T., Overvad, K., Clavel-Chapelon, F., Mesrine, S., Fournier, A., Fortner, R. T., Ose, J., Steffen, A., Trichopoulou, A., Lagiou, P., Orfanos, P., Masala, G., Tumino, R., Sacerdote, C., Polidoro, S., Mattiello, A., Lund, E., Peeters, P. H., Bueno-de-Mesquita, H. B., Quirós, J. R., Sánchez, M.-J., Navarro, C., Barricarte, A., Larrañaga, N., Ekström, J., Lindquist, D., Idahl, A., Travis, R. C., Merritt, M. A., Gunter, M. J., Rinaldi, S., Tommasino, M., Franceschi, S., Riboli, E., & Castellsagué, X.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-01-25
- Volume
- 11
- Issue
- 1
- Pages
- e0147029
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2272590651
- Cited by
- 210
- References
- 4
- FWCI
- 15.54
- Type
- journal article
- Language
- en
- Update notices
- correction (2016-03-08)
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.